Jun 5, 2026 July 6, 2026 Deadline: Key Opportunity for R&D Deductions and Credits
The One Big Beautiful Bill Act (OBBBA), enacted July 4, 2025, restores immediate expensing for domestic R&D costs under new Section 174A and reverses the prior requirement to capitalize and amortize these expenses beginning in 2022; importantly, eligible taxpayers can retroactively apply this treatment to 2022–2024 by filing amended returns under Rev. Proc. 2025-28, allowing full deductions in the year incurred and potentially generating refunds or increasing net operating losses, but action must be taken by July 6, 2026 or earlier if the statute of limitations applies; taxpayers also have a limited opportunity to make or revoke a Section 280C election for those same years, which directly affects how R&D deductions interact with the R&D credit and can materially impact overall tax outcomes; if no action is taken, expenses remain subject to unfavorable amortization rules and the opportunity to optimize both deductions and credits is effectively lost....